May 11, 2020
Vibativ® Sustained Potency Confirmed In Two Surveillance Studies
Apr 28, 2020
Cumberland Pharmaceuticals Releases Inaugural Report On Its Environmental, Social And Governance (ESG) Activities
Apr 07, 2020
To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units
Mar 31, 2020
Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections
Mar 23, 2020
Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
Mar 18, 2020
Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019
Mar 17, 2020
Caldolor® Demonstrates Favorable Safety Profile In Newborns
Mar 06, 2020
Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results
Mar 04, 2020
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2019 Financial Results
Jan 07, 2020
Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product
Jan 02, 2020
Cumberland Pharmaceuticals To Hold Update Call To Discuss Recent Major Developments
Dec 02, 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Nov 25, 2019
New Study Reveals Real-World Usage of Vibativ® In a Variety Of Infections
Nov 12, 2019
Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter
Nov 05, 2019
Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results
Oct 15, 2019
New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia
Sep 24, 2019
Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program
Aug 14, 2019
Cumberland Pharmaceuticals Reports 14% Revenue Growth In The Second Quarter
Aug 07, 2019
Cumberland Pharmaceuticals To Announce Second Quarter 2019 Financial Results
May 15, 2019
Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China